Diociaiuti Marco, Polzi Laura Zanetti, Valvo Luisa, Malchiodi-Albedi Fiorella, Bombelli Cecilia, Gaudiano Maria Cristina
Dipartimento di Tecnologie e Salute, Istituto Superiore di Sanità, 299-00161 Rome, Italy.
Biophys J. 2006 Sep 15;91(6):2275-81. doi: 10.1529/biophysj.105.079475.
Calcitonin is a polypeptidic hormone involved in calcium metabolism in the bone. It belongs to the amyloid protein family, which is characterized by the common propensity to aggregate acquiring a beta-sheet conformation and include proteins associated with important neurodegenerative diseases. Here we show for the first time, to our knowledge, by transmission electron microscopy (TEM) that salmon-calcitonin (sCT) forms annular oligomers similar to those observed for beta-amyloid and alpha-sinuclein (Alzheimer's and Parkinson's diseases). We also investigated the interaction between sCT and model membranes, such as liposomes, with particular attention to the effect induced by lipid "rafts" made of cholesterol and G(M1). We observed, by TEM immunogold labeling of sCT, that protein binding is favored by the presence of rafts. In addition, we found by TEM that sCT oligomers inserted in the membrane have the characteristic pore-like morphology of the amyloid proteins. Circular dichroism experiments revealed an increase in beta-content in sCT secondary structure when the protein was reconstituted in rafts mimicking liposomes. Finally, we showed, by spectrofluorimetry experiments, that the presence of sCT allowed Ca(2+) entry in rafts mimicking liposomes loaded with the Ca(2+)-specific fluorophore Fluo-4. This demonstrates that sCT oligomers have ion-channel activity. Our results are in good agreement with recent electrophysiological studies reporting that sCT forms Ca(2+)-permeable ion channels in planar model membranes. It has been proposed that, beyond the well-known interaction of the monomer with the specific receptor, the formation of Ca(2+) channels due to sCT oligomers could represent an extra source of Ca(2+) entry in osteoblasts. Structural and functional data reported here support this hypothesis.
降钙素是一种参与骨骼钙代谢的多肽激素。它属于淀粉样蛋白家族,其特点是具有共同的聚集倾向,形成β-折叠构象,并且包括与重要神经退行性疾病相关的蛋白质。据我们所知,在此我们首次通过透射电子显微镜(TEM)表明,鲑鱼降钙素(sCT)形成环状寡聚体,类似于在β-淀粉样蛋白和α-突触核蛋白(分别与阿尔茨海默病和帕金森病相关)中观察到的那些。我们还研究了sCT与模型膜(如脂质体)之间的相互作用,特别关注由胆固醇和神经节苷脂GM1构成的脂质“筏”所诱导的效应。通过TEM免疫金标记sCT,我们观察到脂质筏的存在有利于蛋白质结合。此外,通过TEM我们发现插入膜中的sCT寡聚体具有淀粉样蛋白特有的孔状形态。圆二色性实验表明,当蛋白质在模拟脂质筏的脂质体中重构时,sCT二级结构中的β-含量增加。最后,通过荧光光谱实验我们表明,sCT的存在使得Ca(2+)能够进入装载有Ca(2+)特异性荧光团Fluo-4的模拟脂质筏中。这证明sCT寡聚体具有离子通道活性。我们的结果与最近的电生理研究结果高度一致,这些研究报告称sCT在平面模型膜中形成Ca(2+)可渗透的离子通道。有人提出,除了单体与特定受体的众所周知相互作用外,sCT寡聚体形成的Ca(2+)通道可能代表成骨细胞中Ca(2+)进入的额外来源。此处报道的结构和功能数据支持这一假设。